[일:] 2025년 04월 13일

The discussion between BlackRock and the SEC about changing Bitcoin and Ethereum ETF redemptions from cash to physical is notable. This could enhance cryptocurrency credibility and facilitate institutional investment. Additionally, major exchanges are considering 24-hour stock trading, reflecting the influence of the crypto market. Upcoming changes in ETF structures and trading hours may reshape the investment landscape and attract more investors.

GlaxoSmithKline and Pfizer dismissed a U.S. patent lawsuit regarding Pfizer’s RSV vaccine, Abrysvo. Meanwhile, China’s Vice Premier met with major companies to promote foreign investment. The pharmaceutical sector prepares for Medicare drug price negotiations, significantly affecting healthcare costs. Pfizer also agreed to a $60 million settlement over fraud allegations tied to Biohaven Pharmaceuticals. Stock markets declined amid profit-taking and inflation fears, creating a challenging landscape for pharmaceutical companies.

Nubank is expanding beyond Brazil, Mexico, and Colombia, having reported an 87% increase in adjusted net profit. However, shares fell due to unmet revenue expectations. Meanwhile, Shift4 Payments is growing in the hospitality sector, with plans for over 25% revenue growth in 2024. Market trends indicate a volatile response to the U.S. Federal Reserve’s recent interest rate cut, affecting major indices. Both companies signal potential innovation in fintech despite global economic challenges.

Former President Yoon Suk-yeol’s return to politics has energized supporters and attracted investor interest in South Korea. A recent rally demonstrated strong backing for Yoon, signaling potential policy shifts that could favor tech, infrastructure, and green energy sectors. However, the unpredictable political landscape urges caution as investor sentiment may fluctuate. Diversification may mitigate risks linked to this volatility as investors monitor developments closely.